Fundraising Fox
Find your path to H. Martin Seidel, Ph.D.
Sign up to see every warm intro you have to H. Martin Seidel, Ph.D.
- Paths you didn't know you had: your email and LinkedIn already hold routes to H. Martin Seidel, Ph.D.. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Advisor to Lightstone Ventures and CEO of IFM Therapeutics since 2019, with three successful exits generating $750M in realized proceeds and $4B+ in success-based milestones. Martin previously served as Global Head of BD&L at Novartis NIBR and head of the Genomics Institute, advancing 40+ clinical candidates.
Colleagues at Lightstone Ventures
Frequently asked questions
- Who is H. Martin Seidel, Ph.D.?
- Advisor to Lightstone Ventures and CEO of IFM Therapeutics since 2019, with three successful exits generating $750M in realized proceeds and $4B+ in success-based milestones. Martin previously served as Global Head of BD&L at Novartis NIBR and head of the Genomics Institute, advancing 40+ clinical candidates.
- Where does H. Martin Seidel, Ph.D. work?
- H. Martin Seidel, Ph.D. is Advisor at Lightstone Ventures.
About this profile. Compiled from public sources — Lightstone Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights